CLINICAL_TRIALS
trial_result
· 2024-09-20
Clinical Trial Update: Long-Term Follow-up Study of ADVM-043
Summary
Long-term follow-up study of ADVM-043 in Alpha-1 antitrypsin deficiency has completed, with results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Adverum Biotechnologies, Inc. | Conditions: Alpha-1 Antitrypsin Deficiency | Status: COMPLETED | Results posted: 2024-09-20